Coeptis Therapeutics, Inc.
COEP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $533 | $1,469 | $3,791 | $2,180 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $39 | $8 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $518 | $242 | $142 | $0 |
| Total Curr. Assets | $1,051 | $1,750 | $3,942 | $2,180 |
| Property Plant & Equip (Net) | $60 | $109 | $71 | $32 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $542 | $2,554 | $3,554 | $0 |
| Long-Term Investments | $5,691 | $3,500 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1,565 | $158 | $348 | $4,554 |
| Total NC Assets | $7,857 | $6,321 | $3,974 | $4,586 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $8,909 | $8,071 | $7,916 | $6,766 |
| Liabilities | – | – | – | – |
| Payables | $1,270 | $1,420 | $99 | $134 |
| Short-Term Debt | $1,230 | $1,013 | $1,892 | $2,432 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2,013 | $556 | $182 | $199 |
| Total Curr. Liab. | $4,513 | $2,989 | $2,173 | $2,765 |
| LT Debt | $169 | $211 | $165 | $1,650 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $359 | $557 | $1,125 | $0 |
| Total NC Liab. | $528 | $768 | $1,290 | $1,650 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $61 | $61 | $15 | $15 |
| Total Liabilities | $5,041 | $3,757 | $3,462 | $4,415 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $4 | $2 | $4 |
| Retained Earnings | -$98,234 | -$87,356 | -$66,090 | -$27,550 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $101,419 | $91,667 | $70,541 | $29,900 |
| Total Equity | $3,185 | $4,314 | $4,453 | $2,351 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $682 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $8,909 | $8,071 | $7,916 | $6,766 |
| Net Debt | $866 | -$245 | -$1,735 | $1,902 |